• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用微流控流动聚焦装置制备单分散可生物降解聚合物微粒用于控释给药。

Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery.

作者信息

Xu Qiaobing, Hashimoto Michinao, Dang Tram T, Hoare Todd, Kohane Daniel S, Whitesides George M, Langer Robert, Anderson Daniel G

机构信息

Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachussets Avenue, Cambridge, MA 02139, USA.

出版信息

Small. 2009 Jul;5(13):1575-81. doi: 10.1002/smll.200801855.

DOI:10.1002/smll.200801855
PMID:19296563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2789598/
Abstract

Degradable microparticles have broad utility as vehicles for drug delivery and form the basis of several therapies approved by the US Food and Drug Administration. Conventional emulsion-based methods of manufacturing produce particles with a wide range of diameters (and thus kinetics of release) in each batch. This paper describes the fabrication of monodisperse, drug-loaded microparticles from biodegradable polymers using the microfluidic flow-focusing (FF) devices and the drug-delivery properties of those particles. Particles are engineered with defined sizes, ranging from 10 microm to 50 microm. These particles are nearly monodisperse (polydispersity index = 3.9%). A model amphiphilic drug (bupivacaine) is incorporated within the biodegradable matrix of the particles. Kinetic analysis shows that the release of the drug from these monodisperse particles is slower than that from conventional methods of the same average size but a broader distribution of sizes and, most importantly, exhibit a significantly lower initial burst than that observed with conventional particles. The difference in the initial kinetics of drug release is attributed to the uniform distribution of the drug inside the particles generated using the microfluidic methods. These results demonstrate the utility of microfluidic FF for the generation of homogenous systems of particles for the delivery of drugs.

摘要

可降解微粒作为药物递送载体具有广泛的用途,并且是美国食品药品监督管理局批准的几种疗法的基础。传统的基于乳液的制造方法在每一批中都会产生具有广泛直径范围(以及因此具有不同释放动力学)的颗粒。本文描述了使用微流控流动聚焦(FF)装置由可生物降解聚合物制备单分散、载药微粒及其药物递送特性。所制备的微粒尺寸确定,范围从10微米到50微米。这些微粒几乎是单分散的(多分散指数 = 3.9%)。一种模型两亲性药物(布比卡因)被纳入微粒的可生物降解基质中。动力学分析表明,这些单分散微粒中药物的释放比相同平均尺寸但尺寸分布更宽的传统方法制备的微粒慢,并且最重要的是,其初始突释比传统微粒显著更低。药物释放初始动力学的差异归因于使用微流控方法在微粒内部产生的药物均匀分布。这些结果证明了微流控流动聚焦在生成用于药物递送的均匀微粒系统方面的实用性。

相似文献

1
Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery.使用微流控流动聚焦装置制备单分散可生物降解聚合物微粒用于控释给药。
Small. 2009 Jul;5(13):1575-81. doi: 10.1002/smll.200801855.
2
Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.硅基微流控流量聚焦装置用于生产粒径可控的基于 PLGA 的载药微球。
Int J Pharm. 2014 Jun 5;467(1-2):60-9. doi: 10.1016/j.ijpharm.2014.03.051. Epub 2014 Mar 28.
3
Microfluidic preparation of antimicrobial microparticles composed of l-lactide/1,3-dioxolane (co)polymers loaded with quercetin.载有槲皮素的 l-丙交酯/1,3-二氧戊环(共)聚物的抗菌微颗粒的微流体制备。
Food Chem. 2022 Dec 1;396:133639. doi: 10.1016/j.foodchem.2022.133639. Epub 2022 Jul 8.
4
Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.采用流聚焦玻璃微流控器件制备用于药物输送的结构可生物降解聚合物微球。
ACS Appl Mater Interfaces. 2015 Oct 21;7(41):23132-43. doi: 10.1021/acsami.5b06943. Epub 2015 Oct 12.
5
Controlled protein release from monodisperse biodegradable double-wall microspheres of controllable shell thickness.控制壳厚的单分散可生物降解双层微球中蛋白质的控制释放。
J Control Release. 2013 Dec 28;172(3):707-14. doi: 10.1016/j.jconrel.2013.08.009. Epub 2013 Aug 15.
6
Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug-Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection.载西罗莫司的单分散 PLGA 微球,药物-聚合物相分离程度可控,用于药物涂层植入式医疗器械和皮下注射。
ACS Appl Bio Mater. 2022 Aug 15;5(8):3766-3777. doi: 10.1021/acsabm.2c00319. Epub 2022 Jul 16.
7
Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release.制备并表征具有单分散尺寸和均匀壳层的 PLGA-海藻酸钠核壳微球用于控制药物释放。
Acta Biomater. 2013 Jul;9(7):7410-9. doi: 10.1016/j.actbio.2013.03.022. Epub 2013 Mar 25.
8
Controlled release behaviour of protein-loaded microparticles prepared via coaxial or emulsion electrospray.载蛋白微球的同轴或乳液电喷射制备的控释行为。
J Microencapsul. 2013;30(5):490-7. doi: 10.3109/02652048.2012.752537. Epub 2013 Jan 25.
9
Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.可生物降解的乳酸/乙醇酸聚合物的合成、表征、生物降解及药物递送应用:第三部分。药物递送应用。
Artif Cells Blood Substit Immobil Biotechnol. 2004;32(4):575-91. doi: 10.1081/bio-200039635.
10
Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance.尺寸和温度对聚乳酸-乙醇酸共聚物降解及微储库装置性能的影响。
Biomaterials. 2005 May;26(14):2137-45. doi: 10.1016/j.biomaterials.2004.06.033.

引用本文的文献

1
Encapsulation of Therapeutic, Low-Molecular-Weight Chemokines Using a Single Emulsion, Microfluidic, Continuous Manufacturing Process.采用单乳液微流控连续制造工艺封装治疗性低分子量趋化因子
Pharmaceutics. 2025 Aug 14;17(8):1056. doi: 10.3390/pharmaceutics17081056.
2
Process and Formulation Parameters Governing Polymeric Microparticle Formation via Sequential NanoPrecipitation (SNaP).通过连续纳米沉淀法(SNaP)制备聚合物微粒的工艺及配方参数
ACS Eng Au. 2025 Jul 4;5(4):468-477. doi: 10.1021/acsengineeringau.5c00035. eCollection 2025 Aug 20.
3
Development and Characterization of Hyaluronic Acid Microgels for Neural Regeneration Applications.用于神经再生应用的透明质酸微凝胶的开发与表征
J Biomed Mater Res A. 2025 Aug;113(8):e37972. doi: 10.1002/jbm.a.37972.
4
Engineering Moxifloxacin-Encapsulated Liposome-Enriched Alginate Hydrogel Films.工程化含莫西沙星的脂质体富集海藻酸盐水凝胶膜。
Gels. 2025 Jun 11;11(6):448. doi: 10.3390/gels11060448.
5
3D-Printed Microfluidic Platform for Creating Porous Nanofibrous Microspheres to Regulate Cell Response and Enhance Tissue Regeneration.用于制造多孔纳米纤维微球以调节细胞反应并促进组织再生的3D打印微流控平台
Small. 2025 May 2:e2502033. doi: 10.1002/smll.202502033.
6
Investigating How All-Trans Retinoic Acid Polycaprolactone (atRA-PCL) Microparticles Alter the Material Properties of 3D Printed Fibrin Constructs.研究全反式维甲酸聚己内酯(atRA-PCL)微粒如何改变3D打印纤维蛋白构建体的材料特性。
Macromol Biosci. 2025 May;25(5):e2400464. doi: 10.1002/mabi.202400464. Epub 2025 Jan 21.
7
Microfluidic Nanoparticle Separation for Precision Medicine.用于精准医疗的微流控纳米颗粒分离
Adv Sci (Weinh). 2025 Jan;12(4):e2411278. doi: 10.1002/advs.202411278. Epub 2024 Dec 4.
8
Investigation of the Impact of Manufacturing Methods on Protein-Based Long-Acting Injectable Formulations: A Comparative Assessment for Microfluidics vs. Conventional Methods.制造方法对蛋白质基长效注射制剂的影响研究:微流控技术与传统方法的比较评估
Pharmaceutics. 2024 Sep 27;16(10):1264. doi: 10.3390/pharmaceutics16101264.
9
Highly efficient and stable adsorption of lithium from brine with microcapsules containing 1-phenylazo-2-naphthol and trioctylphosphine oxide.含1-苯基偶氮-2-萘酚和三辛基氧化膦的微胶囊对卤水中锂的高效稳定吸附
RSC Adv. 2024 Jul 8;14(30):21307-21317. doi: 10.1039/d4ra03864a. eCollection 2024 Jul 5.
10
Effect of polymer concentration on the morphology of the PHPMAA--PLA graft copolymer nanoparticles produced by microfluidics nanoprecipitation.聚合物浓度对微流控纳米沉淀法制备的PHPMAA-PLA接枝共聚物纳米颗粒形态的影响。
Nanoscale Adv. 2024 Mar 11;6(8):1992-1996. doi: 10.1039/d3na01038d. eCollection 2024 Apr 16.

本文引用的文献

1
Microfluidic platform for controlled synthesis of polymeric nanoparticles.用于可控合成聚合物纳米颗粒的微流控平台。
Nano Lett. 2008 Sep;8(9):2906-12. doi: 10.1021/nl801736q. Epub 2008 Jul 26.
2
Droplet-based microfluidic platforms for the encapsulation and screening of Mammalian cells and multicellular organisms.用于封装和筛选哺乳动物细胞及多细胞生物的基于微滴的微流控平台。
Chem Biol. 2008 May;15(5):427-37. doi: 10.1016/j.chembiol.2008.04.004.
3
Microfluidic large-scale integration on a chip for mass production of monodisperse droplets and particles.用于大规模生产单分散液滴和颗粒的芯片上微流控大规模集成。
Lab Chip. 2008 Feb;8(2):287-93. doi: 10.1039/b713141k. Epub 2007 Nov 23.
4
Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.用于工程药物治疗的纳米制造颗粒:PRINT纳米颗粒的初步生物分布研究
J Control Release. 2007 Aug 16;121(1-2):10-8. doi: 10.1016/j.jconrel.2007.05.027. Epub 2007 Jun 2.
5
Fabrication of monodisperse gel shells and functional microgels in microfluidic devices.在微流控装置中制备单分散凝胶壳和功能性微凝胶。
Angew Chem Int Ed Engl. 2007;46(11):1819-22. doi: 10.1002/anie.200604206.
6
Flowing lattices of bubbles as tunable, self-assembled diffraction gratings.作为可调谐自组装衍射光栅的流动气泡晶格。
Small. 2006 Nov;2(11):1292-8. doi: 10.1002/smll.200600211.
7
Microfluidic production of biopolymer microcapsules with controlled morphology.具有可控形态的生物聚合物微胶囊的微流体制备
J Am Chem Soc. 2006 Sep 20;128(37):12205-10. doi: 10.1021/ja0635682.
8
Continuous-flow lithography for high-throughput microparticle synthesis.用于高通量微粒合成的连续流光刻技术。
Nat Mater. 2006 May;5(5):365-9. doi: 10.1038/nmat1617. Epub 2006 Apr 9.
9
Formation of droplets and bubbles in a microfluidic T-junction-scaling and mechanism of break-up.微流控T型结中液滴和气泡的形成——尺度效应与破裂机制
Lab Chip. 2006 Mar;6(3):437-46. doi: 10.1039/b510841a. Epub 2006 Jan 25.
10
Microgram-scale testing of reaction conditions in solution using nanoliter plugs in microfluidics with detection by MALDI-MS.使用微流控中的纳升塞子对溶液中的反应条件进行微克级测试,并通过基质辅助激光解吸电离质谱(MALDI-MS)进行检测。
J Am Chem Soc. 2006 Mar 1;128(8):2518-9. doi: 10.1021/ja057720w.